Bio Medical

IIT-D ( India ) designs scalable wearable pressure sensor to analyse gait patterns and postural deformities

Sensor can potentially provide an easy, low-cost alternative to expensive footwear modifications...

Shaping the Future of Anaesthesia and Critical Care in India: An Exclusive Interview with Shalin Patel, Managing Director of Draeger India Group

On the occasion of World Anaesthesia Day, MedTech Spectrum & BioSpectrum India delve into the dynamic world of healthcare and technological innovation. We had the privilege of speaking with Mr. Shalin Patel, the Managing Director of Draeger India Group, a prominent player in the medical and safety technology sector....

Boston Scientific Gets FDA Nod for Spinal Cord Stimulation in Diabetic Neuropathy

Nearly 50% of American adults living with diabetes will be affected by diabetic neuropathy complications in their lifetime...

Roche's Fenebrutinib Shows Brain Penetration and Lesion Reduction in Multiple Sclerosis Patients: Late-breaking Data

Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent safety profile to other fenebrutinib trials. The late-breaking data were featured in an oral presentation at the 9th Joint ECTRIMS-ACTRIMS Meeting (European and Americas Committees for Treatment and Research in Multiple Sclerosis)....

DELFI Diagnostics Introduces FirstLook Lung: A Breakthrough in Blood-Based Lung Cancer Screening

FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood...

Mylab transforms new-born screening with breakthrough point-of-care solution

Newborn screening is a critical public health program involving the testing of newborn infants for specific genetic, metabolic, and congenital disorders shortly after birth ...

Fujitsu and iSurgery Launch Osteoporosis Detection Project with Jikei University

Fujitsu Limited and iSurgery Co., Ltd. announced that they will conduct a field trial as part of their “bone health promotion project” from October 2023 to March 2025 in collaboration with the Department of Orthopaedic Surgery at the Jikei University School of Medicine (1), to verify the practicality of bone assessments (2) conducted with chest radiographs and the effects of this approach in changing Fujitsu employees’ attitudes and habits around health. This marks the first time in Japan that ...

Galgotias University and HCL to open medical centre for students in India

Partnership acknowledges the increasing mental health challenges faced by students...

How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Blood-based protein biomarkers have emerged as a promising tool for the early detection of Alzheimer's disease...